![](/img/cover-not-exists.png)
Multiple-Dose Pharmacokinetic Behavior of Elvucitabine, a Nucleoside Reverse Transcriptase Inhibitor, Administered over 21 Days with Lopinavir-Ritonavir in Human Immunodeficiency Virus Type 1-Infected Subjects
Colucci, P., Pottage, J. C., Robison, H., Turgeon, J., Schurmann, D., Hoepelman, I. M., Ducharme, M. P.Volume:
53
Language:
english
Journal:
Antimicrobial Agents and Chemotherapy
DOI:
10.1128/AAC.00907-08
Date:
February, 2009
File:
PDF, 519 KB
english, 2009